Form D — Cyclacel Pharmaceuticals, Inc.
0001829126-25-002044 · filed 2025-03-25
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $1,000,000
- Total sold
- $1,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cyclacel Pharmaceuticals, Inc.
- CIK
- 1130166
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 200 CONNELL DRIVE, SUITE 1500
BERKELEY HEIGHTS, NJ 07922 - Phone
- 908-517-7330
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Datuk Dr. Doris Wong Sing Ee · Executive OfficerBerkeley Heights, NJ Find on LinkedIn ↗
-
Kiu Cu Seng · Executive OfficerBerkeley Heights, NJ Find on LinkedIn ↗
-
Kwang Fock Chong · DirectorBerkeley Heights, NJ Find on LinkedIn ↗
-
David Natan · DirectorBerkeley Heights, NJ Find on LinkedIn ↗
-
Avraham Ben-Tzvi · DirectorBerkeley Heights, NJ Find on LinkedIn ↗
View original on SEC EDGAR.